A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
Recruiting · NCT03547856 · Observational (researchers observe without assigning treatment) · Lead sponsor: Yan Li
View the official record on ClinicalTrials.gov →What this trial is about
24 hour ambulatory blood pressure (ABP) monitoring should be the first choice for diagnosis and treatment of hypertension according to European Societyof Hypertension (ESH) and the European Society of Cardiology (ESC) guideline on ambulatory blood pressure monitoring. Finally, we should promote the clinical application of 24 hour ambulatory blood pressure monitoring to greatly improve the management level of hypertension in China and effectively reduce the risk caused by hypertension in the population. Information of hypertensive patients with ambulatory blood pressure monitoring was prospectively registered nationwide,and then to investigate whether there was difference in cardiovascular prognosis according to the control of ABP.
Who can take part
Inclusion criteria
- Age 18-80 years old
- Clinical diagnosed hypertension with the use of antihypertensive drugs
- A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
- Willing to provide information about disease history and blood biochemical test data within 6 months.
- Sign the informed consent
Exclusion criteria
- Without antihypertensive drug use
- Hospitalized hypertension patients
- Non-compliant patient
Where it is running
1 location listed.
- Ruijin Hospital - Shanghai, Shanghai Municipality, China